Similar Posts
2 No-Brainer Growth Stocks to Buy Right Now for Less Than $500
There’s no question that there’s been a significant divergence in stocks on the TSX in recent months. Some companies have been performing extremely well, while others continue to trade cheaply. However, with interest rates widely expected to continue declining, many of these discounts won’t last much longer. So, if you’re looking for high-quality growth stocks…
How to Build a $40,000 Investment Portfolio That Requires Minimal Maintenance
Building an investment portfolio doesn’t have to be time-consuming or complicated — especially if you’re working with $40,000 and want a hands-off approach. While individual stocks may offer the potential for high returns, they also demand time, research, and the emotional stamina to ride out volatility. If that sounds overwhelming, there’s a much simpler way…
Tuesday: Retail Sales, Industrial Production, Homebuilder Survey
by Calculated Risk on 9/16/2024 07:01:00 PM From Matthew Graham at Mortgage News Daily: Mortgage Rates Inch Lower to Begin Potentially Wild Week The new week began on a relatively quiet note in terms of mortgage rate movement and the underlying bond market. … Traders have quickly shifted back to expecting slightly better odds of…
Neuland Laboratories Shares Gain Over 8% After USFDA Approval for BMS Schizophrenia Drug – Equitypandit
September 27, 2024September 27, 2024 Shares of Neuland Laboratories Ltd. rallied over 8% to reach a day’s high of Rs 13,630.00 on 27th September, following the USFDA approval of Bristol Myers Squibb’s (BMS) new schizophrenia drug, Cobenfy, also known as KarXT. According to market experts, the company is likely…
